Search research articles
Contact Us
Filters
Showing results (141-150 of 392) with videos related to
Page
of 40
Sort By:
Clinical Immunology (Orlando, Fla.)
|
September 14, 2010
The evaluation of catechins that contain a galloyl moiety as potential HIV-1 integrase inhibitors
Fan Jiang, Wei Chen, Kejia Yi, et al.
Frontiers in Oncology
|
March 8, 2021
The Efficacy and Safety of Anlotinib Combined With PD-1 Antibody for Third-Line or Further-Line Treatment of Patients With Advanced Non-Small-Cell Lung Cancer
Chongya Zhai, Xiaoling Zhang, Lulu Ren, et al.
International Journal of Pharmaceutics
|
August 13, 2023
Corrigendum to "Nanodelivery of a self-assembling prodrug with exceptionally high drug loading potentiates chemotherapy efficacy" [Int. J. Pharm. 605 (2021) 120805]
Lulu Ren, Sihang Ren, Liwei Shu, et al.
Scientific Reports
|
January 18, 2024
Association of frailty with mortality in cancer survivors: results from NHANES 1999-2018
Chongya Zhai, Luxi Yin, Jiaying Shen, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
September 13, 2015
Epithelial-mesenchymal transition: An emerging target in tissue fibrosis
Meirong Li, Fuxin Luan, Yali Zhao, et al.
Protein & Cell
|
May 11, 2017
Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
Dongfang Liu, Shuo Tian, Kai Zhang, et al.
Protein & Cell
|
June 25, 2017
Erratum to: Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
Dongfang Liu, Shuo Tian, Kai Zhang, et al.
Plos One
|
March 22, 2013
Culturing on Wharton's jelly extract delays mesenchymal stem cell senescence through p53 and p16INK4a/pRb pathways
Haojie Hao, Guanghui Chen, Jiejie Liu, et al.
Frontiers in Immunology
|
February 7, 2025
Combination chemotherapy with sintilimab for treatment of a male patient with primary pulmonary choriocarcinoma: a case report and literature review
Xiaojing Liang, Guoqing Xu, Jisong Zhang, et al.
International Immunopharmacology
|
October 11, 2020
Efficacy and safety of combined immunotherapy and antiangiogenic therapy for advanced non-small cell lung cancer: A two-center retrospective study
Junlin Yao, Zhengyang Wang, Jin Sheng, et al.
Page
of 40
Search research articles
Search
Showing results (141-150 of 392) with videos related to
Sort By:
Page
of 40
Clinical Immunology (Orlando, Fla.)
|
September 14, 2010
The evaluation of catechins that contain a galloyl moiety as potential HIV-1 integrase inhibitors
Fan Jiang, Wei Chen, Kejia Yi, et al.
Frontiers in Oncology
|
March 8, 2021
The Efficacy and Safety of Anlotinib Combined With PD-1 Antibody for Third-Line or Further-Line Treatment of Patients With Advanced Non-Small-Cell Lung Cancer
Chongya Zhai, Xiaoling Zhang, Lulu Ren, et al.
International Journal of Pharmaceutics
|
August 13, 2023
Corrigendum to "Nanodelivery of a self-assembling prodrug with exceptionally high drug loading potentiates chemotherapy efficacy" [Int. J. Pharm. 605 (2021) 120805]
Lulu Ren, Sihang Ren, Liwei Shu, et al.
Scientific Reports
|
January 18, 2024
Association of frailty with mortality in cancer survivors: results from NHANES 1999-2018
Chongya Zhai, Luxi Yin, Jiaying Shen, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
September 13, 2015
Epithelial-mesenchymal transition: An emerging target in tissue fibrosis
Meirong Li, Fuxin Luan, Yali Zhao, et al.
Protein & Cell
|
May 11, 2017
Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
Dongfang Liu, Shuo Tian, Kai Zhang, et al.
Protein & Cell
|
June 25, 2017
Erratum to: Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
Dongfang Liu, Shuo Tian, Kai Zhang, et al.
Plos One
|
March 22, 2013
Culturing on Wharton's jelly extract delays mesenchymal stem cell senescence through p53 and p16INK4a/pRb pathways
Haojie Hao, Guanghui Chen, Jiejie Liu, et al.
Frontiers in Immunology
|
February 7, 2025
Combination chemotherapy with sintilimab for treatment of a male patient with primary pulmonary choriocarcinoma: a case report and literature review
Xiaojing Liang, Guoqing Xu, Jisong Zhang, et al.
International Immunopharmacology
|
October 11, 2020
Efficacy and safety of combined immunotherapy and antiangiogenic therapy for advanced non-small cell lung cancer: A two-center retrospective study
Junlin Yao, Zhengyang Wang, Jin Sheng, et al.
Page
of 40